Similar articles for PMID: 36863779

Year	Number of Results
1995	1
1996	1
1999	3
2002	1
2004	3
2006	1
2007	4
2008	4
2009	3
2010	1
2011	5
2012	3
2013	6
2014	4
2015	8
2016	11
2017	11
2018	7
2019	4
2020	17
2021	14
2022	9
2023	6
2024	0

1

Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16α-¹⁸F-Fluoro-17β-Fluoroestradiol.

Ulaner GA, Mankoff DA, Clark AS, Fowler AM, Linden HM, Peterson LM, Dehdashti F, Kurland BF, Mortimer J, Mouabbi J, Moon DH, de Vries EGE. Ulaner GA, et al. J Nucl Med. 2023 Mar;64(3):351-354. doi: 10.2967/jnumed.123.265420. J Nucl Med. 2023. PMID: 36863779 Free article.

2

Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.

Kurland BF, Wiggins JR, Coche A, Fontan C, Bouvet Y, Webner P, Divgi C, Linden HM. Kurland BF, et al. Oncologist. 2020 Oct;25(10):835-844. doi: 10.1634/theoncologist.2019-0967. Epub 2020 May 15. Oncologist. 2020. PMID: 32374053 Free PMC article. Review.

3

16α-18F-fluoro-17β-Fluoroestradiol (FES): Clinical Applications for Patients With Breast Cancer.

Ulaner GA. Ulaner GA. Semin Nucl Med. 2022 Sep;52(5):574-583. doi: 10.1053/j.semnuclmed.2022.03.002. Epub 2022 Apr 2. Semin Nucl Med. 2022. PMID: 35379454 Review.

4

The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[¹⁸F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Katzenellenbogen JA. Katzenellenbogen JA. Nucl Med Biol. 2021 Jan;92:24-37. doi: 10.1016/j.nucmedbio.2020.02.007. Epub 2020 Feb 22. Nucl Med Biol. 2021. PMID: 32229068 Free PMC article. Review.

5

Clinical Validity of 16α-[¹⁸F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer.

van Geel JJL, Boers J, Elias SG, Glaudemans AWJM, de Vries EFJ, Hospers GAP, van Kruchten M, Kuip EJM, Jager A, Menke-van der Houven van Oordt WC, van der Vegt B, de Vries EGE, Schröder CP; IMPACT-Metastatic Breast Consortium. van Geel JJL, et al. J Clin Oncol. 2022 Nov 1;40(31):3642-3652. doi: 10.1200/JCO.22.00400. Epub 2022 May 18. J Clin Oncol. 2022. PMID: 35584346

6

PET Imaging of Estrogen Receptors Using ¹⁸F-Based Radioligands.

Kumar M, Salem K, Jeffery JJ, Fowler AM. Kumar M, et al. Methods Mol Biol. 2022;2418:129-151. doi: 10.1007/978-1-0716-1920-9_9. Methods Mol Biol. 2022. PMID: 35119664

7

Diagnostic accuracy and safety of 16α-[¹⁸F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study.

Chae SY, Ahn SH, Kim SB, Han S, Lee SH, Oh SJ, Lee SJ, Kim HJ, Ko BS, Lee JW, Son BH, Kim J, Ahn JH, Jung KH, Kim JE, Kim SY, Choi WJ, Shin HJ, Gong G, Lee HS, Lee JB, Moon DH. Chae SY, et al. Lancet Oncol. 2019 Apr;20(4):546-555. doi: 10.1016/S1470-2045(18)30936-7. Epub 2019 Mar 4. Lancet Oncol. 2019. PMID: 30846327

8

Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy.

Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ. Mortimer JE, et al. Clin Cancer Res. 1996 Jun;2(6):933-9. Clin Cancer Res. 1996. PMID: 9816253

9

Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.

Gemignani ML, Patil S, Seshan VE, Sampson M, Humm JL, Lewis JS, Brogi E, Larson SM, Morrow M, Pandit-Taskar N. Gemignani ML, et al. J Nucl Med. 2013 Oct;54(10):1697-702. doi: 10.2967/jnumed.112.113373. Epub 2013 Aug 22. J Nucl Med. 2013. PMID: 23970364 Free PMC article. Clinical Trial.

10

PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma.

van Kruchten M, Glaudemans AW, de Vries EF, Beets-Tan RG, Schröder CP, Dierckx RA, de Vries EG, Hospers GA. van Kruchten M, et al. J Nucl Med. 2012 Feb;53(2):182-90. doi: 10.2967/jnumed.111.092734. Epub 2012 Jan 12. J Nucl Med. 2012. PMID: 22241912 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year